SCYNEXIS Inc.
Organization details
- Legal name
- SCYNEXIS Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Headquarters city
- Jersey City
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SCYX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001178253
- EIN
- 56-2181648
Board of directors
-
Ann Hanham · DirectorSince 2023
-
Armando Anido · DirectorSince 2023
-
Brian Philippe Tinmouth · DirectorSince 2023
-
David C. Hastings · DirectorSince 2023
-
Gonzalez David Angulo · Director · Chief Executive OfficerSince 2024
-
Guy Macdonald · DirectorSince 2023
-
Steven C. Gilman · DirectorSince 2023
-
Steven Keith Burke · DirectorSince 2026
Chief executives
Director election results
Annual meeting of June 25, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.2%
-
96.3%
-
96.3%
-
96.3%
Board connections
1 of this board's directors also sit on 2 other boards. 2 are in the same sector.
-
Akebia Therapeutics Inc. Same sectorvia Steven C. Gilman
-
Vericel Corporation Same sectorvia Steven C. Gilman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2026 | Steven Keith Burke Director | Grant or award | +5,750 | — | — |
| Jun 26, 2026 | Brian Philippe Tinmouth Director | Grant or award | +2,875 | — | — |
| Jun 26, 2026 | Guy Macdonald Director | Grant or award | +2,875 | — | — |
| Jun 26, 2026 | Armando Anido Director | Grant or award | +2,875 | — | — |
| Jun 26, 2026 | David C. Hastings Director | Grant or award | +2,875 | — | — |
| Jun 26, 2026 | Ann Hanham Director | Grant or award | +2,875 | — | — |
| Apr 1, 2026 | Gonzalez David Angulo Director, Officer (Chief Executive Officer) | Open-market purchase | +108,695 | — | — |
| Jan 29, 2026 | Macleod ivor Officer (Chief Financial Officer) | Grant or award | +129,833 | — | — |
| Jan 29, 2026 | Sukenick Scott Officer (Chief Legal Officer) | Grant or award | +129,833 | — | — |
| Jan 29, 2026 | Gonzalez David Angulo Director, Officer (Chief Executive Officer) | Grant or award | +391,333 | — | — |
| Oct 17, 2025 | Gonzalez David Angulo Director, Officer (Chief Executive Officer) | Grant or award | +32,500 | $0.76 | $24,700 |
| Jun 26, 2025 | Brian Philippe Tinmouth Director | Grant or award | +23,000 | — | — |
| Jun 26, 2025 | Guy Macdonald Director | Grant or award | +23,000 | — | — |
| Jun 26, 2025 | David C. Hastings Director | Grant or award | +23,000 | — | — |
| Jun 26, 2025 | Ann Hanham Director | Grant or award | +23,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about SCYNEXIS Inc.
Who is the CEO of SCYNEXIS Inc.?
Gonzalez David Angulo is SCYNEXIS Inc.'s Chief Executive Officer.
How many directors are on SCYNEXIS Inc.'s board?
SCYNEXIS Inc.'s board has 8 directors: Ann Hanham, Armando Anido, Brian Philippe Tinmouth, David C. Hastings, Gonzalez David Angulo, Guy Macdonald, Steven C. Gilman and Steven Keith Burke.
Are SCYNEXIS Inc. insiders buying or selling shares?
Over the last 12 months, SCYNEXIS Inc. insiders bought $0 of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="scynexis-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.